[EN] A COMPOUND HAVING INHIBITORY ACTIVITY AGAINST KRAS G12D MUTATION<br/>[FR] COMPOSÉ AYANT UNE ACTIVITÉ INHIBITRICE CONTRE LA MUTATION KRAS G12D
申请人:TAIHO PHARMACEUTICAL CO LTD
公开号:WO2021106231A1
公开(公告)日:2021-06-03
The present invention relates to a compound having inhibitory activity against KRAS G12D mutation or a salt thereof, and relates to a pharmaceutical composition comprising the compound as an active ingredient.
本发明涉及一种具有抑制KRAS G12D突变活性或其盐的化合物,并涉及包含该化合物作为活性成分的药物组合物。